Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution

被引:0
作者
S. Müller
P. Schütt
P. Bojko
M. R. Nowrousian
J. Hense
S. Seeber
T. Moritz
机构
[1] University of Duisburg-Essen Medical School,Department of Internal Medicine (Cancer Research), West German Cancer Center
来源
Annals of Hematology | 2005年 / 84卷
关键词
Hemolytic uremic syndrome; Hemolysis; Gemcitabine; Thrombocytopenia; Renal failure; Microangiopathic thrombotic disease;
D O I
暂无
中图分类号
学科分类号
摘要
Hemolytic uremic syndrome (HUS) has been described following the administration of multiple antineoplastic agents, most notably mitomycin C. More recently, several cases of gemcitabine-induced HUS have been observed with the overall incidence of gemcitabine-induced HUS estimated at 0.015–0.25%. We here report on four patients who developed HUS following gemcitabine therapy at our institution within the last year (incidence 1.4%). All these patients had advanced-stage disease, were heavily pretreated, and received prolonged gemcitabine application, suggesting that in this subgroup of patients HUS may be more frequently encountered than documented so far.
引用
收藏
页码:110 / 114
页数:4
相关论文
共 100 条
  • [1] Allford SL(2003)Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias Br J Haematol 120 556-573
  • [2] Hunt BJ(1991)Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients N Engl J Med 325 398-403
  • [3] Rose P(1998)Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome Transfus Sci 19 5-7
  • [4] Machin SJ(1997)Gemcitabine-induced hemolytic uremic syndrome: a case report J Natl Cancer Inst 89 1895-1896
  • [5] Bell WR(1999)A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy Cancer 85 2023-2032
  • [6] Braine HG(1995)Scientific raisins from 127 years SMW (Swiss Medical Weekly). Hemolytic-uremic syndrome: bilateral kidney cortex necrosis in acute acquired hemolytic anemia, 1925 Schweiz Med Wochenschr 125 2528-2532
  • [7] Ness PM(1997)Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol 34 140-147
  • [8] Kickler TS(1996)Clinical, toxicological and pharmacological aspects of gemcitabine Cancer Treat Rev 22 15-31
  • [9] Borghardt EJ(1997)Gemcitabine: a cytidine analogue active against solid tumors Am J Health Syst Pharm 54 162-170
  • [10] Kirchertz EJ(1989)Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry J Clin Oncol 7 781-789